Diabetes Supplement Market - Industry Size, Share, Growth & Forecast 2027 | UnivDatos

 

The presence of well-established healthcare infrastructure and higher adoption of nutraceuticals in the country. Also, the country is witnessing the growing prevalence of prediabetes coupled with the rising geriatric population. For instance, according to the CDC, 96 million people aged 18 years or older have prediabetes (38.0% of the adult US population), and 26.4 million people aged 65 years or older (48.8%) have prediabetes. Furthermore, some other factors boosting the market growth in the country include the increasing cases of obesity owing to the sedentary lifestyles.

The recent COVID-19 pandemic has disrupted the healthcare industry with the emergence of SARS-COV-2. As of March 16, 2021, there have been almost 121 million cases of COVID-19 worldwide. The disease has impacted more than 210 countries and territories, with the United States confirming around one-fifth of all global cases. With this huge surge in the covid cases, the demand for diabetes supplements has also witnessed an uptick as COVID-19 patients as more at a higher risk of diabetes.

Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=21661

According to UnivDatos Market Insights (UMI)’ research report “Global Diabetes Supplement Market Analysis, 2020”, the Diabetes Supplement Market is projected to grow at a CAGR of around 4% during 2021-27F. A large number of ongoing research activities in this field, rising government and public-private investments, and various advantages associated with the diabetes supplements such as controlling blood sugar, preventing diabetes-related complications, and reducing resistance to insulin.

Based on distribution channels, the market is fragmented into hospital pharmacies, retail pharmacies, and online pharmacies. In 2020, the retail pharmacies segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period owing to the availability of retail pharmacies in every small area or city. However, the online segment is also significantly growing due to internet users, ease of access to several brands, 24/7 availability of products, the convenience of shopping, and a wide range of products offered.

Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=21661

Geriatric Segment to Witness Robust growth

Based on end-users, the market is fragmented into adults, geriatric, and children. In 2020, the geriatric segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period owing to the surge of the geriatric population and the growth of the diabetes cases as they are prone to these diseases. For instance, as per NCBI, About 40% (39.5%) of the adult diabetic population is age ≥65 years. Approximately 20% (21.4%) of adults aged≥65 years have a known diagnosis of diabetes.

 

North America to Grab Lion’s Share, and witnessed Explicit Growth

Based on the region, North America dominated the global diabetes supplement market in 2020. The region is projected to maintain its dominance during the forecasted period 2021-27 owing to the presence of well-established market players and frequent product launches in the region. North America is expected to skyrocket with a considerable CAGR in the forecast period, as stated in UnivDatos Market Insights (UMI)’ research report “Global Diabetes Supplement Market Analysis, 2020”. 

For more informative information, please visit us – https://univdatos.com/report/diabetes-supplement-market/

According to UnivDatos Market Insights (UMI)’, the key players with a considerable market share in the Diabetes supplement Market include Novo Nordisk, Nestlà Health Science, Danone Nutricia, NaturoGain, Nature's Bounty, Glucose Health, Inc, Unilever, Bionova Lifesciences, Caelus Health, Abbott among others. The players are focused on launching products for gaining customers' traction and expanding their geographical reach to get a competitive edge in the industry.  

“Global Diabetes Supplement Market Analysis, 2020” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for diabetes supplement providers across the Globe. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitor's capabilities on 16 parameters. This will help companies in the formulation of go to Market Strategies and identifying the blue ocean for its offerings.

For more informative information, please visit us – https://univdatos.com/report/diabetes-supplement-market/

Market Segmentation:

1.      By Ingredients (Vitamins, Minerals, Proteins, Antioxidants & Fatty Acids, Dietary Fibers, and Others)

2.      By Disease Type (Type 1 and Type 2)

3.      By Forms (Tablets, Solution, Powder, and Others)

4.      By Region (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies)

5.      By End-Users (Adults, Geriatric, and Children)

6.      By Region (North America, Europe, Asia-Pacific, Rest of the World)

7.      By Company (Novo Nordisk, Nestle Health Science, Danone Nutricia, NaturoGain, Nature's Bounty, Glucose Health, Inc, Unilever, Bionova Lifesciences, Caelus Health, Abbott Laboratories)

Key questions answered in the study:

1.      What are the current and future trends of the diabetes supplement industry?

2.      How the industry has been evolving in terms of ingredients, disease type,  forms, distribution channel, and end-users?

3.      How the competition has been shaping across the countries followed by their comparative factorial indexing?

4.      What are the key growth drivers and challenges for the diabetes supplement industry?

5.      What is the customer orientation, purchase behavior, and expectations from diabetes supplement firms across various regions?

Table of Content –

1 MARKET INTRODUCTION

2 RESEARCH METHODOLOGY OR ASSUMPTION

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 GLOBAL DIABETES SUPPLEMENT MARKET COVID-19 IMPACT

6 GLOBAL DIABETES SUPPLEMENT MARKET REVENUE, 2019-2027F

7 MARKET INSIGHTS BY INGREDIENTS

8 MARKET INSIGHTS BY DISEASE TYPE

9 MARKET INSIGHTS BY FORMS

10 MARKET INSIGHTS BY DISTRIBUTION CHANNEL

11 MARKET INSIGHTS BY END-USERS

12 MARKET INSIGHTS BY REGION

13 DIABETES SUPPLEMENT MARKET DYNAMICS

14 DIABETES SUPPLEMENT MARKET OPPORTUNITIES

15 DIABETES SUPPLEMENT MARKET TRENDS

16 LEGAL & REGULATORY FRAMEWORK

17 DEMAND AND SUPPLY SIDE ANALYSIS

18 VALUE CHAIN ANALYSIS

19 COMPETITIVE SCENARIO

20 COMPANY PROFILED

21 DISCLAIMER

Browse Other Related Research Reports from UnivDatos Market Insights

·        3D Printed Drugs Market to Reach US$ 2,064.8 Million by 2027 Globally | CAGR: 15.2% |

·        Gene Therapy Market to Reach US$ 20.9 Billion by 2027, Globally |CAGR: 29.7%|

·        Healthcare Cloud Computing Market to Reach US$ 80.5 Billion by 2027 Globally |CAGR: 14.5%| 

·        Virtual Healthcare Delivery Market to Reach US$ 122 Billion by 2027 Globally |CAGR: 24.6%|